Tropicamide/phenylephrine
Tropicamide/phenylephrine, sold under the brand name Mydcombi is a fixed dose combination of tropicamide and phenylephrine used to dilate the eyes (mydriasis).
≈ 1 min read
Tropicamide/phenylephrine. encyclopegia.org, snapshot enwiki-001331685563. /a/tropicamide-phenylephrine
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Tropicamide/phenylephrine, sold under the brand name Mydcombi is a fixed dose combination of tropicamide and phenylephrine used to dilate the eyes (mydriasis). It contains, tropicamide, an anticholinergic, and phenylephrine, as the hydrochloride, an alpha-1 adrenergic receptor agonist. It is sprayed into the eyes. It was approved for medical use in the United States in May 2023.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1331685563 under CC BY-SA 4.0; modifications have been made.